Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01527149||Active, not recruiting||Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma||
||Other / NIH||
||37||All||18 Years to 70 Years (Adult, Senior)||NCT01527149||I 201611
|December 6, 2011||October 5, 2020||October 5, 2021||February 6, 2012||January 29, 2018||